Ainos (AIMD) Stock Analysis
NASDAQHealthcareBiotechnology
What Ainos does
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Key metrics
ETFs linked to AIMD
Broad-market and Healthcare sector ETFs an investor holding Ainos is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how AIMD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze AIMD in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Ainos?
- Ainos trades under the ticker AIMD on NASDAQ.
- Which exchange is AIMD listed on?
- AIMD is listed on NASDAQ.
- What sector does Ainos operate in?
- Ainos is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze AIMD in a portfolio?
- PortView shows AIMD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.